25 June 2018
Human Rights of People living with a Rare Disease highlighted in Official Statement at Human Rights Council
As NGOs with ECOSOC Consultative Status, Thalassaemia International Federation, the Agrenska Foundation, and the International Federation for Hydrocephalus and Spina Bifida – IF, submitted a statement to the 38th Session of the Human Rights Council (18 June – 6 July, Geneva) endorsing the messages laid out in the NGO Committee for Rare Diseases publication ‘The ‘Right to Health’ in Rare Diseases’.
The Official Written Statement reinstated how several of the challenges faced by persons with rare diseases intersect the main pillars of the “right to health” framework including Accessibility, Availability, Participation and Good Quality, meaning that rare diseases must be addressed as both a human rights and public health issue.
As a reminder, the ‘The ‘Right to Health’ in Rare Diseases’ was a contribution made by the NGO Committee for Rare Diseases in the context of the open consultation by the Office of the High Commissioner for Human Rights (OHCHR) for the “Report on the contributions of the right to health framework to the effective implementation and achievement of the health-related Sustainable Development Goals”. This report, which highlights the need to attend to the rights of “persons with disabilities and other populations and groups in vulnerable situations”, was presented by Ms. Kate Gilmore, UN Deputy High Commissioner for Human Rights, at the 38th Session of the Human Rights Council. The OHCHR received a high number of contributions to it, including the one on rare diseases, which can be found here.
13 June 2018
NGO Committee for Rare Diseases delivers an oral statement at the United Nations Conference on Disability
On behalf of the NGO Committee for Rare Diseases, Clara Hervás, Public Affairs Junior Manager, EURORDIS-Rare Diseases Europe, delivered a statement at the Conference of State Parties to the Convention on the Rights of Persons with Disabilities at the United Nations (UN) in New York on Wednesday 13th June.
This conference, which is an annual gathering of stakeholders and signatory Member States, took place from 12 to 14 June at the UN Headquarters in New York under the overarching theme: ‘Leaving no one behind through the full implementation of the CRPD’.
The NGO Committee for Rare Diseases was among the few civil society representatives allowed to make a statement during the General Debate of the Conference. The statement called for the UN to ‘pay attention to the diversity within the community of people living with disability and ensure that people living with a rare disease across all regions of the world are not in fact left behind’ in the implementation of the Convention on the Rights of Persons with Disabilities.
22 May 2018
Rare diseases mentioned for the first time at WHO 71st World Health Assembly
Paloma Tejada, Director of Rare Diseases International (RDI), member organisation of the NGO Committee, delivered an official statement at the World Health Assembly of the World Health Organisation (WHO) in Geneva (Monday 21 to Friday 26 May). The statement is the product of a joint collaboration between the umbrella organisations that are members of the NGO Committee for Rare Diseases and a number of organisations holding the status of ‘special relations with the WHO’ (Thalassaemia International Federation, World Federation of Hemophilia, International Alliance of Patients’ Organizations and March of Dimes).
The statement is anchored to agenda item ‘11.7 Preparation for the third High-level Meeting of the General Assembly on the Prevention and Control of Non-communicable Diseases, to be held in 2018’. It calls on Member States to “not leave behind significant but often neglected rare diseases, each of which affect relatively small numbers of patients but collectively affect at least 300 million people globally”. Key messages of the statement include: to ACKNOWLEDGE the severity of the problem; to PROMOTE national strategies; to ADVOCATE for available and affordable medicines; and to DEVELOP synergies across borders.